Post publication note
While correct at the time of publication, the information provided in the letter below no longer reflects the regulatory position. Valproate medicines are contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met. See Drug Safety Update April 2018 for more information.
In February 2016, a letter was sent to healthcare professionals regarding: